Centre Antoine Lacassagne - Service d'Hématologie Oncologie

Nice

1 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Head and Neck Cancer, Solid Tumors

Studies at this site

• Anti-GD2 ADC M3554 in Advanced Solid Tumors — Recruiting now
• Avelumab Program Rollover Study — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early